Could GLP-1 Be Causing Your Hair Thinning
(Nasdaq: NRBO), a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases, today announced that pre-clinical data suggests that DA-1241, a novel G-Protein-Coupled Receptor 119 (GPR119) agonist, in combination with semaglutide (Wegovy), improves liver fibrosis and demonstrates additive hepatoprotective effects in pre-clinical metabolic dysfunction-associated steatohepatitis (MASH) models compared to either treatment alone
Your doctor will help determine which option is best for you, considering factors such as effectiveness, safety profile, and your personal preferences
Debunking the myth: Scientific basis: GLP-1 agonists are not just another diet pill
After the injection, apply gentle pressure with a cotton ball but avoid rubbing the area
It's especially useful for patients with chronic fatigue, Long COVID, suspected poor mitochondrial function, and those recovering from substance addiction